StartsidaSTAR • NSE
add
Strides Pharma Science Ltd
Föregående stängning
1 643,30 ₹
Dygnsintervall
1 593,55 ₹ - 1 654,95 ₹
Årsintervall
467,00 ₹ - 1 675,00 ₹
Börsvärde
149,79 md INR
Genomsnittlig volym
349,47 tn
P/E-tal
3 343,12
Direktavkastning
0,15 %
Primär börs
NSE
Ekonominyheter
Ekonomi
Resultaträkning
Intäkter
Nettoinkomst
(INR) | juni 2024info | Förändring Y/Y |
---|---|---|
Intäkter | 10,88 md | 16,94 % |
Rörliga kostnader | 4,99 md | 13,84 % |
Nettoinkomst | 702,02 mn | 1 086,95 % |
Nettovinstmarginal | 6,46 | 950,00 % |
Vinst per aktie | — | — |
EBITDA | 2,24 md | 33,22 % |
Giltig skattesats | 19,80 % | — |
Balansräkning
Totala tillgångar
Totala ansvarsskyldigheter
(INR) | juni 2024info | Förändring Y/Y |
---|---|---|
Kontanta och kortsiktiga investeringar | 2,97 md | −19,05 % |
Totala tillgångar | — | — |
Totala ansvarsskyldigheter | — | — |
Totala tillgångar | 20,72 md | — |
Utestående aktier | 91,89 mn | — |
P/B | 7,10 | — |
Avkastning på tillgångar | — | — |
Avkastning på kapital | 9,17 % | — |
Kassaflöde
Förändring i nettokassa
(INR) | juni 2024info | Förändring Y/Y |
---|---|---|
Nettoinkomst | 702,02 mn | 1 086,95 % |
Kontanter från verksamhet | — | — |
Kontanter från investering | — | — |
Kontanter från finansiering | — | — |
Förändring i nettokassa | — | — |
Fritt kassaflöde | — | — |
Om
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Grundades
1990
Huvudkontor
Hemsida
Anställda
3 065